Login/Sign Up
What precautions should a 48-year-old postmenopausal patient take during the one-month gap after completing a three-month course of medroxyprogesterone acetate (Meprate) for simple endometrial hyperplasia without atypia before her follow-up scan, and is she expected to experience withdrawal bleeding or a return of her period after stopping the medication?
What precautions should a 48-year-old postmenopausal patient take during the one-month gap after completing a three-month course of medroxyprogesterone acetate (Meprate) for simple endometrial hyperplasia without atypia before her follow-up scan, and is she expected to experience withdrawal bleeding or a return of her period after stopping the medication?
Answered 20 days ago